HDAC9 and infection: The pan-HDAC inhibitor trichostatin A and class IIa HDAC inhibitor TMP195 have been shown to be very effective in reducing M. tuberculosis infection in primary human macrophages and a Mycobacterium marinum-zebrafish infection model (62).